Burns: Clinical Trials

9 trials for Burns, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Terminated 9

Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plasma Resuscitation Without Lung Injury
Pathogen-Reduced Plasma, Crystalloid Solutions - Burns
Phase 4TerminatedCoalition for National Trauma Research132022-08-172025-01-29
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
Ceftolozane/tazobactam - Burns, Pharmacokinetics
Phase 4TerminatedTexas Tech University Health Sciences Center62017-08-212021-03-02
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
Collagenase Santyl, Bacitracin - Burn, Partial Thickness
Phase 4TerminatedUniversity of Kansas Medical Center202013-09-302024-07-10
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
Sertraline, Placebo oral capsule - Post-traumatic Stress Disorder
Phase 4TerminatedUniversity of Utah52013-09-012018-04-10
Fluid Resuscitation in Patients Suffering From Burns Injury
Volulyte, Human Serum Albumin - Burns
Phase 4TerminatedFresenius Kabi112012-12-012014-06-26
Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients
Fenofibrate, Sugar Pill - Second or Third Degree Burns
Phase 4TerminatedThe University of Texas Medical Branch, Galveston32012-05-012019-11-29
The Effect of Selenium Supplementation Among Pediatric Patients With Burns
Selenium1, Selenium2, Placebo - Burns
Phase 4TerminatedShriners Hospitals for Children142009-01-012021-07-29
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
Sulfamylon® For 5 % Topical Solution, Topical Antimicrobial/Antifungal Medications - Burns
Phase 4TerminatedMylan Inc.2202007-09-012022-09-29
Comparison of Monitored Anesthesia Care Using Remifentanil or Fentanyl for Major Dressing Changes in Burns
remifentanil - Burns, Pain
Phase 4TerminatedMontreal Burn Centre402005-08-012006-10-13

Narrower conditions

Insulin Resistance (1)  ·  Neoplasm Metastasis (1)  ·  Pain (1)  ·  Stress Disorders, Post-Traumatic (1)

Broader conditions

Wounds and Injuries (9)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Neurologic Manifestations (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Bacitracin (2)  ·  Amphotericin B (1)  ·  Anti-Infective Agents (1)  ·  Crystalloid Solutions (1)  ·  Fenofibrate (1)  ·  Hydroxyethyl Starch Derivatives (1)  ·  Mafenide (1)  ·  Remifentanil (1)  ·  Sertraline (1)  ·  Serum Albumin, Human (1)  ·  Sodium Chloride (1)  ·  Solutions (1)  ·  Sugars (1)  ·  ceftolozane, tazobactam drug combination (1)

Sponsors

Coalition for National Trauma Research (1)  ·  Fresenius Kabi (1)  ·  Montreal Burn Centre (1)  ·  Mylan Inc. (1)  ·  Shriners Hospitals for Children (1)  ·  Texas Tech University Health Sciences Center (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of Kansas Medical Center (1)  ·  University of Utah (1)

Countries

United States (7)  ·  Canada (1)  ·  United Kingdom (1)

Top investigators

Brent M Kious, MD PhD (1)  ·  David Bracco, MD (1)  ·  David N Herndon, MD (1)  ·  Dhaval Bhavsar, MD (1)  ·  Eric Davis, MD (1)  ·  Leopoldo Cancio, MD (1)  ·  Maggie L Dylewski, PhD,RD (1)  ·  Naiem Moiemen, PhD MD (1)  ·  Ronald G Hall, PharmD (1)

Results publications

PMID 41212678